Join our expert as they delve into the critical aspects of recognizing and diagnosing peripartum cardiomyopathy (PPCM), a serious heart condition affecting pregnant and postpartum women. This episode will cover guideline-directed medical therapy tailored for PPCM during pregnancy and the postpartum period. Additionally, postpartum care strategies will be explored along with a patient's personal journey to provide a comprehensive understanding of the condition.

The future of primary care in relation to COVID-19 in 2025 is shaped by several key trends and strategies. Join our speakers as they discuss resilience, innovation, how to utilize the most recent application of scientific findings to ensure optimal patient outcomes and much more. CE and ABIM MOC credits available: https://bit.ly/3R2wJoi

Addressing social determinants of health (SDOH) requires a multifaceted approach involving various sectors and stakeholders. There are population groups and underlying medical conditions that can increase the risk of mild to moderate COVID-19 infection, progressing to a severe outcome. The speakers will discuss these aspects and provide strategies for change.  CE and ABIM MOC credits available: 

https://bit.ly/4k0q2jY

In this episode, learn from leading experts about managing preeclampsia with and without severe features. The panel will define the pathophysiology and potential for multi-organ system impact with preeclampsia; discussion to include postpartum care recommendations. 

Claim CE and MOC credit here: https://bit.ly/ManagePreeclampsia

In this episode, hear from leading experts as they define the major health issues in hypertensive disorders of pregnancy. Learn how to outline the appropriate work-up to diagnose hypertensive disorders of pregnancy; discussion to include recommended medications as well as postpartum care.

Claim CE and MOC credit here https://bit.ly/ChronicHTN

In this episode Dr. Paul Ridker discusses the pivotal role of high-sensitivity C-reactive protein (hsCRP), a biomarker for inflammation, in cardiovascular prevention and treatment. He explains how inflammation and cholesterol together drive atherosclerosis, the significance of hsCRP testing, and the latest clinical trial findings. Dr. Ridker also highlights the importance of primary prevention strategies and the potential of targeted anti-inflammatory therapies to revolutionize cardiovascular care.

In this episode, Dr. Brittany Weber discusses the role of inflammation and high-sensitivity CRP (hs-CRP) in cardiovascular disease. She explores the connection between inflammation and atherosclerosis and how immune system activation contributes to atherosclerosis development, the importance of endothelial damage and pro-inflammatory cytokines, and the impact of systemic inflammatory diseases on cardiovascular risk. Tune in to learn about the mechanisms behind inflammation in cardiovascular disease and the significance of hsCRP as a biomarker.

In this episode, Dr. Amir Rezvan hosts a panel discussion with distinguished colleagues Dr. Paul Ridker, Dr. Brendan Everett, Dr. Michael Garshick, and Dr. Kaitlin Voigts Key. The panel explores what high-sensitivity CRP (hs-CRP) is and its normal levels, the role of hsCRP in diagnosing and treating atherosclerotic disease, and how inflammation and hyperlipidemia contribute to cardiovascular events. The panel provides practical advice on measuring hsCRP and interpreting high values. Tune in for this insightful discussion on the importance of hsCRP in preventive cardiology and how to effectively use this biomarker in clinical practice.

In this episode, Dr. Brendan Everett discusses how lifestyle changes can reduce low-grade systemic inflammation. He explores the impact of weight loss on high-sensitivity CRP (hs-CRP)levels, the benefits of different diet types, and the role of exercise and smoking cessation in managing inflammation. Watch now to learn how lifestyle interventions can play a crucial role in reducing inflammation and improving cardiovascular health.

In this episode, Dr. Michael Garshick discusses the role of pharmacologic interventions in managing inflammation and high-sensitivity CRP (hs-CRP) in cardiovascular (CV) disease. Key topics include the involvement of inflammation in atherosclerosis and atherothrombosis, traditional targets such as dyslipidemia, hypertension, and antiplatelet therapy, and the complexity of targeting inflammation and the inflammasome signaling pathway. He also explores insights from the CANTOS trial on IL-1 beta inhibitors and their impact on CV events and the role of colchicine in reducing CV events and its safety profile. Watch now to learn about the latest advancements in pharmacologic strategies for reducing cardiovascular risk through inflammation management.